N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen

C174H186Br2N20O20S — CID 159085874

IUPACN-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen
SMILESCC(=O)Nc1ccc(OCCCNC(=O)C(=O)c2c[nH]c3ccc(Br)cc23)cc1.COc1ccccc1N1CCN(C(=O)C(=O)c2c[nH]c3ccc(Br)cc23)CC1.Cc1ccc(Cn2cc(SCCNC(=O)C(=O)c3c[nH]c4ccccc34)c3ccccc32)cc1.O=C(C(=O)N(Cc1ccccc1)Cc1ccccc1)c1c[nH]c2ccccc12.O=C(NC(CN1CCOCC1)c1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NC(c1ccccc1)c1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NCCc1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NCc1ccccc1)C(=O)c1c[nH]c2ccccc12.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C28H25N3O2S.C24H20N2O2.C23H18N2O2.C22H23N3O3.C21H20BrN3O4.C21H20BrN3O3.C18H16N2O2.C17H14N2O2.15H2/c1-19-10-12-20(13-11-19)17-31-18-26(22-7-3-5-9-25(22)31)34-15-14-29-28(33)27(32)23-16-30-24-8-4-2-6-21(23)24;27-23(21-15-25-22-14-8-7-13-20(21)22)24(28)26(16-18-9-3-1-4-10-18)17-19-11-5-2-6-12-19;26-22(19-15-24-20-14-8-7-13-18(19)20)23(27)25-21(16-9-3-1-4-10-16)17-11-5-2-6-12-17;26-21(18-14-23-19-9-5-4-8-17(18)19)22(27)24-20(16-6-2-1-3-7-16)15-25-10-12-28-13-11-25;1-13(26)25-15-4-6-16(7-5-15)29-10-2-9-23-21(28)20(27)18-12-24-19-8-3-14(22)11-17(18)19;1-28-19-5-3-2-4-18(19)24-8-10-25(11-9-24)21(27)20(26)16-13-23-17-7-6-14(22)12-15(16)17;21-17(15-12-20-16-9-5-4-8-14(15)16)18(22)19-11-10-13-6-2-1-3-7-13;20-16(14-11-18-15-9-5-4-8-13(14)15)17(21)19-10-12-6-2-1-3-7-12;;;;;;;;;;;;;;;/h2-13,16,18,30H,14-15,17H2,1H3,(H,29,33);1-15,25H,16-17H2;1-15,21,24H,(H,25,27);1-9,14,20,23H,10-13,15H2,(H,24,27);3-8,11-12,24H,2,9-10H2,1H3,(H,23,28)(H,25,26);2-7,12-13,23H,8-11H2,1H3;1-9,12,20H,10-11H2,(H,19,22);1-9,11,18H,10H2,(H,19,21);15*1H
InChIKeyKBLBVTDPRMRFFZ-UHFFFAOYSA-N
MW3069.40 g/mol
LogP33.14
Rot. Bonds46

About N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen

N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen (PubChem CID 159085874) has the molecular formula C174H186Br2N20O20S and a molecular weight of 3069.40 g/mol. Its IUPAC name is N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen.

Molecular Properties

Compound NameN-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen
PubChem CID159085874
Molecular FormulaC174H186Br2N20O20S
Molecular Weight3069.40 g/mol
Exact Mass3065.22
IUPAC NameN-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen
SMILESCC(=O)Nc1ccc(OCCCNC(=O)C(=O)c2c[nH]c3ccc(Br)cc23)cc1.COc1ccccc1N1CCN(C(=O)C(=O)c2c[nH]c3ccc(Br)cc23)CC1.Cc1ccc(Cn2cc(SCCNC(=O)C(=O)c3c[nH]c4ccccc34)c3ccccc32)cc1.O=C(C(=O)N(Cc1ccccc1)Cc1ccccc1)c1c[nH]c2ccccc12.O=C(NC(CN1CCOCC1)c1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NC(c1ccccc1)c1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NCCc1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NCc1ccccc1)C(=O)c1c[nH]c2ccccc12.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C28H25N3O2S.C24H20N2O2.C23H18N2O2.C22H23N3O3.C21H20BrN3O4.C21H20BrN3O3.C18H16N2O2.C17H14N2O2.15H2/c1-19-10-12-20(13-11-19)17-31-18-26(22-7-3-5-9-25(22)31)34-15-14-29-28(33)27(32)23-16-30-24-8-4-2-6-21(23)24;27-23(21-15-25-22-14-8-7-13-20(21)22)24(28)26(16-18-9-3-1-4-10-18)17-19-11-5-2-6-12-19;26-22(19-15-24-20-14-8-7-13-18(19)20)23(27)25-21(16-9-3-1-4-10-16)17-11-5-2-6-12-17;26-21(18-14-23-19-9-5-4-8-17(18)19)22(27)24-20(16-6-2-1-3-7-16)15-25-10-12-28-13-11-25;1-13(26)25-15-4-6-16(7-5-15)29-10-2-9-23-21(28)20(27)18-12-24-19-8-3-14(22)11-17(18)19;1-28-19-5-3-2-4-18(19)24-8-10-25(11-9-24)21(27)20(26)16-13-23-17-7-6-14(22)12-15(16)17;21-17(15-12-20-16-9-5-4-8-14(15)16)18(22)19-11-10-13-6-2-1-3-7-13;20-16(14-11-18-15-9-5-4-8-13(14)15)17(21)19-10-12-6-2-1-3-7-12;;;;;;;;;;;;;;;/h2-13,16,18,30H,14-15,17H2,1H3,(H,29,33);1-15,25H,16-17H2;1-15,21,24H,(H,25,27);1-9,14,20,23H,10-13,15H2,(H,24,27);3-8,11-12,24H,2,9-10H2,1H3,(H,23,28)(H,25,26);2-7,12-13,23H,8-11H2,1H3;1-9,12,20H,10-11H2,(H,19,22);1-9,11,18H,10H2,(H,19,21);15*1H
InChIKeyKBLBVTDPRMRFFZ-UHFFFAOYSA-N
XLogP33.14
TPSA546.30 Ų
H-Bond Donors15
H-Bond Acceptors24
Rotatable Bonds46
Heavy Atoms217
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003069.40
LogP ≤ 533.14
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;molecular hydrogen
CID 159498501
N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide
CID 160242148
2-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-1,3-benzoxazole;N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-1H-indole-2-carboxamide;N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-4-methoxybenzamide;N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-1H-pyrrole-2-carboxamide;N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)thiophene-2-carboxamide
CID 161197919
N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen
CID 161574611

Frequently Asked Questions

What is the IUPAC name of N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen?
The IUPAC name of N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen (CID 159085874) is N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen.
What is the SMILES notation for N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen?
The canonical SMILES for N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen is CC(=O)Nc1ccc(OCCCNC(=O)C(=O)c2c[nH]c3ccc(Br)cc23)cc1.COc1ccccc1N1CCN(C(=O)C(=O)c2c[nH]c3ccc(Br)cc23)CC1.Cc1ccc(Cn2cc(SCCNC(=O)C(=O)c3c[nH]c4ccccc34)c3ccccc32)cc1.O=C(C(=O)N(Cc1ccccc1)Cc1ccccc1)c1c[nH]c2ccccc12.O=C(NC(CN1CCOCC1)c1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NC(c1ccccc1)c1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NCCc1ccccc1)C(=O)c1c[nH]c2ccccc12.O=C(NCc1ccccc1)C(=O)c1c[nH]c2ccccc12.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen?
The InChIKey is KBLBVTDPRMRFFZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H25N3O2S.C24H20N2O2.C23H18N2O2.C22H23N3O3.C21H20BrN3O4.C21H20BrN3O3.C18H16N2O2.C17H14N2O2.15H2/c1-19-10-12-20(13-11-19)17-31-18-26(22-7-3-5-9-25(22)31)34-15-14-29-28(33)27(32)23-16-30-24-8-4-2-6-21(23)24;27-23(21-15-25-22-14-8-7-13-20(21)22)24(28)26(16-18-9-3-1-4-10-18)17-19-11-5-2-6-12-19;26-22(19-15-24-20-14-8-7-13-18(19)20)23(27)25-21(16-9-3-1-4-10-16)17-11-5-2-6-12-17;26-21(18-14-23-19-9-5-4-8-17(18)19)22(27)24-20(16-6-2-1-3-7-16)15-25-10-12-28-13-11-25;1-13(26)25-15-4-6-16(7-5-15)29-10-2-9-23-21(28)20(27)18-12-24-19-8-3-14(22)11-17(18)19;1-28-19-5-3-2-4-18(19)24-8-10-25(11-9-24)21(27)20(26)16-13-23-17-7-6-14(22)12-15(16)17;21-17(15-12-20-16-9-5-4-8-14(15)16)18(22)19-11-10-13-6-2-1-3-7-13;20-16(14-11-18-15-9-5-4-8-13(14)15)17(21)19-10-12-6-2-1-3-7-12;;;;;;;;;;;;;;;/h2-13,16,18,30H,14-15,17H2,1H3,(H,29,33);1-15,25H,16-17H2;1-15,21,24H,(H,25,27);1-9,14,20,23H,10-13,15H2,(H,24,27);3-8,11-12,24H,2,9-10H2,1H3,(H,23,28)(H,25,26);2-7,12-13,23H,8-11H2,1H3;1-9,12,20H,10-11H2,(H,19,22);1-9,11,18H,10H2,(H,19,21);15*1H.
What are the key properties of N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen?
N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen has a molecular weight of 3069.40 g/mol, XLogP of 33.14, 46 rotatable bonds, 15 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(4-acetamidophenoxy)propyl]-2-(5-bromo-1H-indol-3-yl)-2-oxoacetamide;N-benzhydryl-2-(1H-indol-3-yl)-2-oxoacetamide;N-benzyl-2-(1H-indol-3-yl)-2-oxoacetamide;1-(5-bromo-1H-indol-3-yl)-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethane-1,2-dione;N,N-dibenzyl-2-(1H-indol-3-yl)-2-oxoacetamide;2-(1H-indol-3-yl)-N-[2-[1-[(4-methylphenyl)methyl]indol-3-yl]sulfanylethyl]-2-oxoacetamide;2-(1H-indol-3-yl)-N-(2-morpholin-4-yl-1-phenylethyl)-2-oxoacetamide;2-(1H-indol-3-yl)-2-oxo-N-(2-phenylethyl)acetamide;molecular hydrogen is sourced from PubChem (CID 159085874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).